Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of ED-Initiated Vivitrol and Case Management for AUD
NCT04094584Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Aug 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by University of California, San Francisco. Started Aug 2020; status: terminated.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04094584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094584.